SEC Form 4 research
| Issuer | Ginkgo Bioworks Holdings, Inc. |
|---|---|
| Tickers | DNA, SRNG |
| Reporting owners | 34 |
| Officers and directors | 8 |
| Last public filing | 2026-10-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-21 | 2026-10-19 | Coen Steven P. | S | 766 | $10.14 | Not reported |
| 2026-10-21 | 2026-10-19 | Canton Barry | S | 22,369 | $10.14 | Not reported |
| 2026-10-21 | 2026-10-19 | Canton Barry | S | 18,803 | $10.14 | Not reported |
| 2026-10-21 | 2026-10-19 | Shetty Reshma P. | S | 18,803 | $10.14 | Not reported |
| 2026-10-21 | 2026-10-19 | Shetty Reshma P. | S | 22,369 | $10.14 | Not reported |
| 2026-10-21 | 2026-10-19 | Kelly Jason R | S | 45,682 | $10.14 | Not reported |
| 2026-10-07 | 2026-10-05 | Coen Steven P. | S | 2,403 | $15 | Not reported |
| 2026-09-16 | 2026-09-15 | HENRY CHRISTIAN O | S | 5,000 | $7.08 | Not reported |
| 2026-08-25 | 2026-08-24 | Coen Steven P. | S | 330 | $6.98 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.